Erik H.F.M. van der Heijden

Author

Also Known As

E van der Heijden, E. H. F. M. van der Heijden, E. Van Der Heijden, E. van der Heijden, E.H.F.M. van der Heijden, Erik H.F.M. van der Heijden, Erik F.M. van der Heijden, Erik H F M van der Heijden, Erik H. F. M. Van Der Heijden, Erik H. F. M. van der Heijden

223

Publications

11.5K

Citations

H-Index

Concepts

All Affiliations

Radboud University Nijmegen Radboud University Medical Center Leiden University Medical Center University of Liverpool The University of Texas MD Anderson Cancer Center

About

Erik H.F.M. van der Heijden is an author at Radboud University Nijmegen specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.4K
2	Health Sciences	13	14	377
3	Engineering	4	4	84
4	Public Health	4	4	287
5	Anesthesia	1	1	21

Erik H.F.M. van der Heijden

Publications

Citations

H-Index

Page 1

	Year	Citations
High Performance of <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography and Contrast-Enhanced CT in a Rapid Outpatient Diagnostic Program for Patients with Suspected Lung Cancer Pepijn Brocken, Erik H.F.M. van der Heijden, P.N.R. Dekhuijzen, Respiration	2013	4K
Obesity, metabolic factors and risk of different histological types of lung cancer: A Mendelian randomization study Robert Carreras‐Torres, Mattias Johansson, Philip Haycock, PLoS ONE	2017	659
Endosonography vs Conventional Bronchoscopy for the Diagnosis of Sarcoidosis Martin B. von Bartheld, Olaf M. Dekkers, Artur Szlubowski, JAMA	2013	230
Increased risk of lung cancer in individuals with a family history of the disease: A pooled analysis from the International Lung Cancer Consortium Michele L. Coté, Mei Liu, Stefano Bonassi, European Journal of Cancer Family MedicineEpidemiologyCancer RiskCancer EpidemiologyMedicine	2012	201
Efficiency, Efficacy, and Safety of EZ-Blocker Compared with Left-sided Double-lumen Tube for One-lung Ventilation Jo Mourisse, Jordi Liesveld, Ad F. T. M. Verhagen, Anesthesiology	2013	146
Glucose Metabolism in NSCLC Is Histology-Specific and Diverges the Prognostic Potential of 18FDG-PET for Adenocarcinoma and Squamous Cell Carcinoma Olga C.J. Schuurbiers, Tineke W.H. Meijer, J.H.A.M. Kaanders, Journal of Thoracic Oncology Tumoral PathologyGlucose MetabolismMalignant DiseaseSquamous Cell CarcinomaMedicine	2014	132
Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4 Tineke W.H. Meijer, Olga C.J. Schuurbiers, Johannes H.A.M. Kaanders, Lung Cancer OncologyCell Lung CarcinomasMedicinePrognostic ValuePathology	2011	117
Chemotherapy Response Evaluation with 18F-FDG PET in Patients with Non-Small Cell Lung Cancer Lioe‐Fee de Geus‐Oei, Erik H.F.M. van der Heijden, Eric P. Visser, Journal of Nuclear Medicine	2007	114
<sup>18</sup>F-FDG PET Early Response Evaluation of Locally Advanced Non–Small Cell Lung Cancer Treated with Concomitant Chemoradiotherapy Edwin A. Usmanij, Lioe‐Fee de Geus‐Oei, Esther G.C. Troost, Journal of Nuclear Medicine	2013	112
A Brief Retrospective Report on the Feasibility of Epidermal Growth Factor Receptor and KRAS Mutation Analysis in Transesophageal Ultrasound- and Endobronchial Ultrasound-Guided Fine Needle Cytological Aspirates Olga C.J. Schuurbiers, Monika Looijen-Salamon, Marjolijn J. L. Ligtenberg, Journal of Thoracic Oncology Medical UltrasoundMedicineHistopathologyPathologyUltrasound	2010	110

Page 1